Page 142 - Read Online
P. 142

Turati et al. Hepatoma Res 2022;8:19  https://dx.doi.org/10.20517/2394-5079.2021.130  Page 15 of 15

                   population-based case-control study. Clin Gastroenterol Hepatol 2007;5:1221-8.  DOI  PubMed  PMC
               27.      Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a
                   population-based study in SEER-Medicare. PLoS One 2017;12:e0186643.  DOI  PubMed  PMC
               28.      Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-
                   control study. Am J Gastroenterol 2007;102:1016-21.  DOI  PubMed
               29.      Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? J Hepatol 2012;57:69-76.  DOI
                   PubMed  PMC
               30.      De Lorenzo S, Tovoli F, Mazzotta A, et al. Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its
                   prognostic role. Cancers (Basel) 2020;12:3182.  DOI  PubMed  PMC
               31.      Jing W, Jin G, Zhou X, et al. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev
                   2012;21:24-31.  DOI  PubMed
               32.      Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, et al. Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver
                   cancer pooling project and meta-analysis. Am J Gastroenterol 2018;113:1494-505.  DOI  PubMed  PMC
               33.      Corrao S, Natoli G, Argano C. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with
                   extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis. Eur J Gastroenterol Hepatol 2021;33:62-8.
                   DOI
               34.      El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-
                   based study of U.S. veterans. Hepatology 2009;49:116-23.  DOI  PubMed  PMC
               35.      Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a
                   systematic review and meta-analysis. J Hepatol 2020;72:95-103.  DOI  PubMed
               36.      Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults
                   by sex and age, 2007-2008 to 2015-2016. JAMA 2018;319:1723-5.  DOI  PubMed  PMC
               37.      Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an
                   exponential increase in burden of disease. Hepatology 2018;67:123-33.  DOI  PubMed  PMC
               38.      Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016.
                   Hepatology 2019;69:1020-31.  DOI  PubMed  PMC
               39.      C e n t e r s   f o r   D i s e a s e   C o n t r o l   a n d   P r e v e n t i o n .   V i r a l   h e p a t i t i s   s u r v e i l l a n c e ,   2 0 1 9 .   A v a i l a b l e   f r o m  :
                   https://www.cdc.gov/hepatitis/statistics/2019surveillance/index.htm [Last accessed on 2 Apr 2022].  DOI
               40.      La Vecchia C, Bosetti C, Bertuccio P, et al. Trends in alcohol consumption in Europe and their impact on major alcohol-related
                   cancers. Eur J Cancer Prev 2014;23:319-22.  DOI  PubMed
               41.      Ferrone CR, Ting DT, Shahid M, et al. The Ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched
                   DNA-enhanced albumin RNA in situ hybridization technology. Ann Surg Oncol 2016;23:290-6.  DOI  PubMed  PMC
               42.      Tyson GL, Ilyas JA, Duan Z, et al. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of
                   misclassification. Dig Dis Sci 2014;59:3103-10.  DOI  PubMed  PMC
               43.      Bertuccio P, Turati F, Carioli G, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol 2017;67:302-9.
                   DOI  PubMed
               44.      Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J
                   Cancer 1999;79:640-4.  DOI  PubMed  PMC
               45.      Levi F, Lucchini F, Negri E, La Vecchia C. The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev
                   2003;12:265-7.  DOI  PubMed
               46.      Bertuccio P, Turati F, Carioli G, et al. Reply to: “How to predict global trends in HCC mortality if neglect more than half the world’s
                   cases? J Hepatol 2017;67:888.  DOI  PubMed
   137   138   139   140   141   142   143   144   145   146   147